Healthstream (HSTM) Cash & Current Investments (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash & Current Investments data on file, last reported at $66.5 million in Q1 2026.

• On a quarterly basis, Cash & Current Investments fell 41.32% year-over-year to $66.5 million in Q1 2026; TTM through Mar 2026 was $66.5 million, a 41.32% decrease from a year earlier, with the FY2025 full-year figure at $57.0 million, down 41.36% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $66.5 million, up from $57.0 million in the prior quarter.
• Over the last five years, Cash & Current Investments for HSTM reached as high as $113.3 million in Q1 2025 and fell as low as $39.2 million in Q2 2022.
• Historically, Cash & Current Investments has averaged $72.2 million across 5 years, with a median of $71.1 million in 2023.
• Across the five-year window, Cash & Current Investments soared 48.31% in 2024 and plunged 41.36% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $53.9 million in 2022, then soared by 31.95% to $71.1 million in 2023, then soared by 36.67% to $97.2 million in 2024, then plunged by 41.36% to $57.0 million in 2025, then climbed by 16.65% to $66.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $66.5 million in Q1 2026, $57.0 million in Q4 2025, and $92.6 million in Q3 2025.